Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade.
Kobayashi T, Iwama S, Yamagami A, Yasuda Y, Okuji T, Ito M, Zhou X, Ando M, Onoue T, Miyata T, Sugiyama M, Hagiwara D, Suga H, Banno R, Hase T, Morise M, Ito T, Kikumori T, Inoue M, Ando Y, Masuda N, Kawashima H, Hashimoto N, Arima H.
Kobayashi T, et al. Among authors: sugiyama m.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4115-e4123. doi: 10.1210/clinem/dgac467.
J Clin Endocrinol Metab. 2022.
PMID: 35918067